Literature DB >> 22113441

Thioredoxin interacting protein (TXNIP) rs7212 polymorphism is associated with arterial stiffness in the Brazilian general population.

R O Alvim1, P C J L Santos, N E Ferreira, J G Mill, J E Krieger, A C Pereira.   

Abstract

Thioredoxin interacting protein plays a pivotal role in several important processes of cardiovascular homeostasis by functioning as a biological sensor for biomechanical and oxidative stress. However, the effects of genetic variants in the modulation of arterial stiffness are unknown. In this scenario, the present study evaluated the relationship between the TXNIP rs7212 polymorphism and arterial stiffness. In the overall sample and in the diabetic group, individuals carrying CG+GG genotypes had higher PWV values compared with CC genotype group (10.0 vs 9.8 m s (-1), P=0.03; 12.3 vs 11.2 m s(-1), P=0.01; respectively). Our findings indicated that the G allele may contribute to increased arterial stiffness in the Brazilian general population and suggest a possible interaction with diabetes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22113441     DOI: 10.1038/jhh.2011.102

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  11 in total

Review 1.  Genetic determinants of arterial stiffness.

Authors:  Jeongok G Logan; Mary B Engler; Hyungsuk Kim
Journal:  J Cardiovasc Transl Res       Date:  2014-12-04       Impact factor: 4.132

2.  Txnip ablation reduces vascular smooth muscle cell inflammation and ameliorates atherosclerosis in apolipoprotein E knockout mice.

Authors:  Chang Hyun Byon; Tieyan Han; Judy Wu; Simon T Hui
Journal:  Atherosclerosis       Date:  2015-06-03       Impact factor: 5.162

3.  Galectin-3 induces vascular smooth muscle cells calcification via AMPK/TXNIP pathway.

Authors:  Lei Tian; Yong Wang; Ruiyan Zhang
Journal:  Aging (Albany NY)       Date:  2022-06-27       Impact factor: 5.955

4.  MYLIP p.N342S polymorphism is not associated with lipid profile in the Brazilian population.

Authors:  Paulo C J L Santos; Theo G M Oliveira; Pedro A Lemos; José G Mill; José E Krieger; Alexandre C Pereira
Journal:  Lipids Health Dis       Date:  2012-06-28       Impact factor: 3.876

5.  Associations of polymorphisms in TXNIP and gene-environment interactions with the risk of coronary artery disease in a Chinese Han population.

Authors:  Xue-Bin Wang; Ya-di Han; Shuai Zhang; Ning-Hua Cui; Ze-Jin Liu; Zhu-Liang Huang; Cong Li; Fang Zheng
Journal:  J Cell Mol Med       Date:  2016-07-29       Impact factor: 5.310

Review 6.  The Emerging Role of TXNIP in Ischemic and Cardiovascular Diseases; A Novel Marker and Therapeutic Target.

Authors:  Alison Domingues; Julia Jolibois; Perrine Marquet de Rougé; Valérie Nivet-Antoine
Journal:  Int J Mol Sci       Date:  2021-02-08       Impact factor: 5.923

Review 7.  The Emerging Role of Metabolism in Brain-Heart Axis: New Challenge for the Therapy and Prevention of Alzheimer Disease. May Thioredoxin Interacting Protein (TXNIP) Play a Role?

Authors:  Lorena Perrone; Mariarosaria Valente
Journal:  Biomolecules       Date:  2021-11-08

8.  BDKRB2 +9/-9 polymorphism is associated with higher risk for diabetes mellitus in the Brazilian general population.

Authors:  Rafael de Oliveira Alvim; Paulo C J L Santos; Raimundo M Nascimento; George L L M Coelho; José G Mill; José E Krieger; Alexandre C Pereira
Journal:  Exp Diabetes Res       Date:  2012-11-29

9.  Higher incidence of death in multi-vessel coronary artery disease patients associated with polymorphisms in chromosome 9p21.

Authors:  Luciana Gioli-Pereira; Paulo Caleb Junior Lima Santos; Noely Evangelista Ferreira; Whady Armindo Hueb; Jose Eduardo Krieger; Alexandre Costa Pereira
Journal:  BMC Cardiovasc Disord       Date:  2012-08-02       Impact factor: 2.298

10.  LPA rs10455872 polymorphism is associated with coronary lesions in Brazilian patients submitted to coronary angiography.

Authors:  Paulo Cjl Santos; Carolina T Bueno; Pedro A Lemos; José E Krieger; Alexandre C Pereira
Journal:  Lipids Health Dis       Date:  2014-04-29       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.